Runben Biotechnology (SH:603193) Sou Hu Cai Jing·2025-08-25 16:04Core Points - The stock price of Runben Co., Ltd. (603193) closed at 30.59 yuan on August 25, 2025, down 1.77% with a turnover rate of 7.73% and a trading volume of 79,900 lots, amounting to 245 million yuan [1] - The company experienced a net outflow of main funds amounting to 58.92 million yuan, accounting for 24.08% of the total transaction amount, with significant outflows from large orders [1] - Runben's latest financial results show total operating revenue of 895 million yuan, a year-on-year increase of 20.31%, and a net profit attributable to shareholders of 188 million yuan, up 4.16% year-on-year [1] Financial Metrics - The company's non-deductible net profit reached 177 million yuan, reflecting a year-on-year growth of 0.86% [1] - Current ratio stands at 10.497, quick ratio at 9.660, and debt-to-asset ratio at 6.98% [1] Company Overview - Runben Biotechnology Co., Ltd. was established in 2013 and is located in Guangzhou, primarily engaged in the manufacturing of chemical raw materials and products [2] - The company has a registered capital of 4,045.93314 million yuan and the same amount in paid-in capital [1] - The legal representative of the company is Zhao Guiqin [1] Investment and Intellectual Property - Runben has made investments in 8 enterprises and participated in 13 bidding projects [2] - The company holds 106 trademark registrations and 109 patents, along with 64 administrative licenses [2]